29.04.2005 12:32:00

Nonlinear Dynamics Announces More Details of Its Global Partnership wi

Nonlinear Dynamics Announces More Details of Its Global Partnership with PerkinElmer


    Pharmaceutical Writers/Business Editors/Biotech Writers
    BIOWIRE2K

    NEWCASTLE-UPON-TYNE, England--(BUSINESS WIRE)--April 29, 2005--Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, today announced further details of its global OEM partnership with PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions.
    As detailed in a press release issued last week, PerkinElmer will distribute Nonlinear's full range of 1D, 2D and array software. However the agreement also represents the formation of an integrated partnership between the two companies, with Nonlinear now formally established as PerkinElmer's principal software partner for all proteomics applications.
    Mary Lopez, Business Leader for Analytical Proteomics at PerkinElmer said, "PerkinElmer was eager to establish a single strong proteomics software and bioinformatics partner going into 2005 and beyond. In entering this collaboration with Nonlinear, we are firmly endorsing Nonlinear Dynamics as that partner. The product and corporate synergies between PerkinElmer and Nonlinear made this a natural choice to benefit our customers into the future."
    She continued, "PerkinElmer is re-launching its gel imaging strategy this year with ProXPRESS, our new consumables and Nonlinear's software as the centrepieces to that strategy. Our intention is to reaffirm PerkinElmer as the first choice in gel imaging, whether it be for 1D or 2D gels, blots or any other applications."
    John Spreadbury, Group Sales and Marketing Director of Nonlinear Dynamics and CEO of Nonlinear USA Inc., added, "Nonlinear has provided PerkinElmer with software for a number of years now and we are very excited by this positive assertion by PerkinElmer of Nonlinear's central role within its proteomics strategy. Together we have a number of new initiatives which we are already working on. We are confident that the extensive fruits of this relationship will continue to benefit the proteomics community for many years to come."

    About Nonlinear Dynamics Ltd

    Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company's innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of partners and OEM resellers.

    About PerkinElmer

    PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics, and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of its customers' needs, PerkinElmer creates innovative solutions - backed by unparalleled service and support - for customers in health sciences, semiconductor, aerospace, and other markets whose applications demand absolute precision and speed. The Company markets in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

--30--SM/lo*

CONTACT: Nonlinear Dynamics Ltd Operational Marketing Manager James Sykes, +44 191 230 2121 james.sykes@nonlinear.com www.nonlinear.com or PerkinElmer, Inc. Investor Contact Media Contact Dan Sutherby, +1 (781) 431-4306 or Brodeur Worldwide Karen McManus, +1 (617) 587-2860

KEYWORD: UNITED KINGDOM INTERNATIONAL EUROPE INDUSTRY KEYWORD: MEDICAL DEVICES PHARMACEUTICAL MEDICAL BIOTECHNOLOGY SOFTWARE MARKETING AGREEMENTS SOURCE: Nonlinear Dynamics Ltd

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu PerkinElmer Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PerkinElmer Inc. 98,54 -2,39% PerkinElmer Inc.

Indizes in diesem Artikel

S&P 500 5 667,56 0,08%